Back
Amgen 10K Form
Sell
36
AMGN
Amgen
Last Price:
230.94
Seasonality Move:
8.23%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-04-28 | 10Q | AMGN/Amgen Quarterly |
| 2021-02-09 | 10K | AMGN/Amgen Annual |
| 2020-10-29 | 10Q | AMGN/Amgen Quarterly |
| 2020-07-29 | 10Q | AMGN/Amgen Quarterly |
| 2020-05-01 | 10Q | AMGN/Amgen Quarterly |
| 2020-02-13 | 10K | AMGN/Amgen Annual |
Receive AMGN News And Ratings
See the #1 stock for the next 7 days that we like better than AMGN
AMGN Financial Statistics
Sales & Book Value
| Annual Sales: | $25.98B |
|---|---|
| Cash Flow: | $1.68B |
| Price / Cash Flow: | 15.35 |
| Annual Sales: | $4.52 |
| Price / Book: | 51.07 |
Profitability
| EPS (TTM): | 11.80000 |
|---|---|
| Net Income (TTM): | $6.58B |
| Gross Margin: | $19.53B |
| Return on Equity: | 124.08% |
| Return on Assets: | 10.8% |
Amgen Earnings Forecast
Key Amgen Financial Ratios
- The Gross Profit Margin over the past 38 years for AMGN is 75.16%.
- The Selling, General & Administrative Expenses for AMGN have been equal to 20.66% of Gross Profit Margin.
- The Research & Development expenses have been 18.55% of Revenue.
- The Interest Expense is 20.31% of Operating Income.
- The Net Earning history of AMGN is 22.68% of Total Revenues.
- Per Share Earnings over the last 38 years have been positive in 24 years.
Amgen Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Drug Manufacturers - General |
| Sector: | Healthcare |
| Current Symbol: | AMGN |
| CUSIP: | 031162 |
| Website: | amgen.com |
Debt
| Debt-to-Equity Ratio: | 15.1 |
|---|---|
| Current Ratio: | 1.53 |
| Quick Ratio: | 0.99 |
Price-to-Earnings
| Trailing P/E Ratio: | 22.47 |
|---|---|
| Forward P/E Ratio: | 12.25 |